Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
Sensing Atrial High Rate Episodes With DX System in Implantable Cardioverter Defibrillators Trial
Status: Enrolling
Updated:  12/31/1969
264
mi
from 02139
Philadelphia, PA
Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
Sensing Atrial High Rate Episodes With DX System in Implantable Cardioverter Defibrillators Trial
Status: Enrolling
Updated: 12/31/1969
Einstein Medical Center
264
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
Sensing Atrial High Rate Episodes With DX System in Implantable Cardioverter Defibrillators Trial
Status: Enrolling
Updated:  12/31/1969
939
mi
from 02139
Nashville, TN
Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
Sensing Atrial High Rate Episodes With DX System in Implantable Cardioverter Defibrillators Trial
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
939
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation
Pilot Study of OFDI Capsule Imaging of the Esophagus of Patients With Atrial Fibrillation Following RF Ablation
Status: Enrolling
Updated:  12/31/1969
1
mi
from 02139
Boston, MA
OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation
Pilot Study of OFDI Capsule Imaging of the Esophagus of Patients With Atrial Fibrillation Following RF Ablation
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1
mi
from 02139
Boston, MA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
2586
mi
from 02139
Glendale, CA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Glendale Memorial Hospital and Health Center
2586
mi
from 02139
Glendale, CA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
2620
mi
from 02139
Sacramento, CA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Regional Cardiology Associates
2620
mi
from 02139
Sacramento, CA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
929
mi
from 02139
Atlanta, GA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
929
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
1247
mi
from 02139
Kansas City, KA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Kansas University Medical Center
1247
mi
from 02139
Kansas City, KA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
821
mi
from 02139
Louisville, KY
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
University of Louisville
821
mi
from 02139
Louisville, KY
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
1
mi
from 02139
Boston, MA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1
mi
from 02139
Boston, MA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
2
mi
from 02139
Boston, MA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
640
mi
from 02139
Flint, MI
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Cardiology Consultants of East Michigan
640
mi
from 02139
Flint, MI
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
617
mi
from 02139
Southfield, MI
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Providence Hospital
617
mi
from 02139
Southfield, MI
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
1253
mi
from 02139
Jackson, MS
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Jackson Heart Clinic
1253
mi
from 02139
Jackson, MS
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
127
mi
from 02139
Stony Brook, NY
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Stony Brook University Medical Center
127
mi
from 02139
Stony Brook, NY
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
544
mi
from 02139
Cleveland, OH
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
544
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
2524
mi
from 02139
Portland, OR
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Providence Heart & Vascular Institute
2524
mi
from 02139
Portland, OR
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
270
mi
from 02139
Philadelphia, PA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
270
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
819
mi
from 02139
Charleston, SC
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
819
mi
from 02139
Charleston, SC
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
940
mi
from 02139
Nashville, TN
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Centennial Medical Center
940
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
1690
mi
from 02139
Austin, TX
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Texas Cardiac Arrhythmia
1690
mi
from 02139
Austin, TX
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
490
mi
from 02139
Charlottesville, VA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
University of Virginia Medical Center
490
mi
from 02139
Charlottesville, VA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
140
mi
from 02139
New York, NY
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
140
mi
from 02139
New York, NY
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
1605
mi
from 02139
Houston, TX
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital
1605
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
Alert-Based Computerized Decision Support for Stroke Prevention in High-Risk Hospitalized Patients With Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)
Status: Enrolling
Updated:  12/31/1969
2
mi
from 02139
Boston, MA
Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
Alert-Based Computerized Decision Support for Stroke Prevention in High-Risk Hospitalized Patients With Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone vs Hybrid Ablation With PVI Plus Catheter Ablation
Prospective, Randomized Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone Versus Hybrid Ablation With Pulmonary Vein Isolation Plus Catheter Ablation for CFAE and Linear Lesions
Status: Enrolling
Updated:  12/31/1969
855
mi
from 02139
Milwaukee, WI
Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone vs Hybrid Ablation With PVI Plus Catheter Ablation
Prospective, Randomized Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone Versus Hybrid Ablation With Pulmonary Vein Isolation Plus Catheter Ablation for CFAE and Linear Lesions
Status: Enrolling
Updated: 12/31/1969
Aurora Health Care, St. Luke's Medical Center
855
mi
from 02139
Milwaukee, WI
Click here to add this to my saved trials
Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Status: Enrolling
Updated:  12/31/1969
2597
mi
from 02139
Torrance, CA
Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Status: Enrolling
Updated: 12/31/1969
Los Angeles Biomedical Research Institute
2597
mi
from 02139
Torrance, CA
Click here to add this to my saved trials
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI
Status: Enrolling
Updated:  12/31/1969
mi
from 02139
New York, NY
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from 02139
New York, NY
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
2577
mi
from 02139
San Diego, CA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hospital
2577
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
2572
mi
from 02139
San Diego, CA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Sharp Memorial Hospital
2572
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
2653
mi
from 02139
Santa Barbara, CA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Santa Barbara Cottage Hospital
2653
mi
from 02139
Santa Barbara, CA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
1202
mi
from 02139
Atlantis, FL
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
JFK Medical Center
1202
mi
from 02139
Atlantis, FL
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
1114
mi
from 02139
Orlando, FL
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Florida Hospital Orlando
1114
mi
from 02139
Orlando, FL
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
927
mi
from 02139
Atlanta, GA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Emory Saint Joseph's Hospital
927
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
769
mi
from 02139
Lexington, KY
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Central Baptist Hospital
769
mi
from 02139
Lexington, KY
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
1
mi
from 02139
Boston, MA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1
mi
from 02139
Boston, MA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
1120
mi
from 02139
Minneapolis, MN
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Abbott Northwestern Hospital
1120
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
321
mi
from 02139
Hershey, PA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center
321
mi
from 02139
Hershey, PA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
270
mi
from 02139
Philadelphia, PA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
270
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
1691
mi
from 02139
Austin, TX
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Texas Cardiac Arrhythmia Research Foundation - St. David's
1691
mi
from 02139
Austin, TX
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
1560
mi
from 02139
Bedford, TX
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
HeartPlace
1560
mi
from 02139
Bedford, TX
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
1601
mi
from 02139
Houston, TX
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Memorial Hermann Medical Center
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
2600
mi
from 02139
Santa Monica, CA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Providence Saint John's Health Center / Pacific Heart Institute
2600
mi
from 02139
Santa Monica, CA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
2
mi
from 02139
Boston, MA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
186
mi
from 02139
New York, NY
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
NYU Langone Medical Center
186
mi
from 02139
New York, NY
Click here to add this to my saved trials
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Status: Enrolling
Updated:  12/31/1969
2
mi
from 02139
Boston, MA
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
984
mi
from 02139
Huntsville, AL
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Local Institution
984
mi
from 02139
Huntsville, AL
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
2675
mi
from 02139
Fremont, CA
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Washington Township Medical Foundation
2675
mi
from 02139
Fremont, CA
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
2598
mi
from 02139
Reseda, CA
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Local Institution
2598
mi
from 02139
Reseda, CA
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
1108
mi
from 02139
Altamonte Springs, FL
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Orlando Heart Specialists
1108
mi
from 02139
Altamonte Springs, FL
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
763
mi
from 02139
Elkhart, IN
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Elkhart Clinic, LLC
763
mi
from 02139
Elkhart, IN
Click here to add this to my saved trials